XML 104 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net income $ 2,218 $ 5,258
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss (gain) on sale / purchase of businesses and other assets (2,039) 389
Impairment of goodwill 0 100
Depreciation and amortization 2,764 2,848
Amortization of deferred financing costs 232 (638)
Accretion of debt discount on convertible subordinated notes 171 0
Provision for losses on accounts receivable 700 456
Stock-based compensation expense 1,491 646
Deferred income taxes (4,780) 1,354
Loss on redemption of convertible junior subordinated debentures 2,932 0
Other (3) (34)
Changes in operating assets and liabilities that provided (required) cash:    
Accounts and preneed receivables (245) (1,904)
Inventories and other current assets 299 478
Deferred charges and other (318) 21
Preneed funeral and cemetery trust investments (5,258) 1,410
Accounts payable (2,566) (874)
Accrued and other liabilities (2,387) (280)
Deferred preneed funeral and cemetery revenue (37) 2,617
Deferred preneed funeral and cemetery receipts held in trust 5,208 (1,934)
Net cash provided by (used in) operating activities (1,618) 9,913
Cash flows from investing activities:    
Acquisitions and new construction 0 (6,051)
Net proceeds from the sale of businesses and other assets 200 2,011
Capital expenditures (5,048) (2,602)
Net cash used in investing activities (4,848) (6,642)
Cash flows from financing activities:    
Net payments on the revolving credit facility (36,900) (1,700)
Payments on term loan (3,000) (2,500)
Proceeds from the issuance of convertible subordinated notes 143,750 0
Payment of debt issuance costs related to the convertible subordinated notes (4,355) 0
Payments on other long-term debt and obligations under capital leases (185) (168)
Redemption of convertible junior subordinated debentures (61,905) 0
Payments for performance-based stock awards (16,150) 0
Proceeds from the exercise of stock options and employee stock purchase plan contributions 652 318
Dividends on common stock (456) (452)
Dividend on redeemable preferred stock 0 (4)
Payment of loan origination costs 5,596 (98)
Excess tax benefit of equity compensation 0 925
Net cash provided by (used in) financing activities 27,047 (3,679)
Net increase (decrease) in cash and cash equivalents 20,581 (408)
Cash and cash equivalents at beginning of period 1,377  
Cash and cash equivalents at end of period $ 21,958